HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Structure-activity relationships of a new antifungal imidazole, AFK-108, and related compounds.

Abstract
Fungicidal activity of widely used imidazole antifungal drugs in topical applications is not so strong in spite of their fungistatic activities against dermatophytes and pathogenic yeasts. In order to improve fungicidal activity of imidazole antifungal agents, a series of novel imidazole derivatives having a hydrophobic substituent derived from isoprenoid were synthesized. The efficacy of these compounds was evaluated with respect to direct cell-membrane damaging activity, ergosterol biosynthesis inhibition, minimum growth-inhibitory concentration (MIC) and therapeutic effect for experimental dermatophytosis of guinea pigs. Among the newly synthesized compounds, the geranyl derivative named AFK-108 (2a) showed the highest in vivo fungicidal activity with both cell membrane damaging activity and ergosterol biosynthesis inhibition in vitro.
AuthorsK Hori, A Sakaguchi, M Kudoh, K Ishida, Y Aoyama, Y Yoshida
JournalChemical & pharmaceutical bulletin (Chem Pharm Bull (Tokyo)) Vol. 48 Issue 1 Pg. 60-4 (Jan 2000) ISSN: 0009-2363 [Print] Japan
PMID10705477 (Publication Type: Journal Article)
Chemical References
  • Antifungal Agents
  • Imidazoles
  • AFK 108
  • Ergosterol
Topics
  • Animals
  • Antifungal Agents (chemistry, pharmacology, therapeutic use)
  • Candida albicans (drug effects, metabolism)
  • Cell Membrane (drug effects)
  • Chromatography, Thin Layer
  • Dermatomycoses (drug therapy)
  • Ergosterol (biosynthesis)
  • Guinea Pigs
  • Imidazoles (chemistry, pharmacology, therapeutic use)
  • Lipid Metabolism
  • Microbial Sensitivity Tests
  • Structure-Activity Relationship
  • Trichophyton (drug effects, metabolism)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: